CCM
STJ

Catapult Capital Management’s St Jude Medical STJ Stock Holding History

Catapult Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,326
Closed -$479K – 280
2014
Q1 		$479K Sell
7,326
-58,472
-89% -$3.81M 0.1% 157
2013
Q4 		$4.08M Buy
65,798
+10,798
+20% +$625K 0.97% 29
2013
Q3 		$2.95M Buy
+55,000
New +$2.83M 0.36% 92

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Catapult Capital Management's STJ Position: Q2 2014 in Review

Catapult Capital Management sold out of St Jude Medical (STJ) in Q2 2014, closing a stake of 7,326 shares — an estimated $479K sold.

Catapult Capital Management first reported a position in STJ in Q3 2013 and held it in 3 quarters. The position peaked at $4.08M in Q4 2013. 555 funds tracked by Wall St. Rank hold STJ as of Q2 2014.

  • Catapult Capital Management reported no remaining St Jude Medical position as of Q2 2014 after selling out during the quarter.
  • Catapult Capital Management sold 7,326 St Jude Medical shares in Q2 2014, an estimated $479K.
  • Catapult Capital Management first reported a position in St Jude Medical in Q3 2013 and held it in 3 quarters.
  • Catapult Capital Management's St Jude Medical position peaked at $4.08M in Q4 2013.
  • 555 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2014.

Based on Catapult Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.